spacer gif spacer gif spacer gif spacer gif Propose a workshop for 2011 spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search    

The fully linked HTML version of this article has now been published.
JCS ePress online publication date 27 Feb 2007
doi: 10.1242/jcs.003335


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcs.003335v1
120/6/1050    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hojilla, C. V.
Right arrow Articles by Khokha, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hojilla, C. V.
Right arrow Articles by Khokha, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Research Article

Metalloproteinase axes increase {beta}-catenin signaling in primary mouse mammary epithelial cells lacking TIMP3


Carlo V. Hojilla, Ira Kim, Zamaneh Kassiri, Jimmie E. Fata, Hui Fang, and Rama Khokha*
* Author for correspondence (e-mail: rkhokha{at}uhnres.utoronto.ca)

Multiple cancers exhibit mutations in {beta}-catenin that lead to increased stability, altered localization or amplified activity. {beta}-catenin is situated at the junction between the cadherin-mediated cell adhesion and Wnt signaling pathways, and TIMP3 functions to alter {beta}-catenin signaling. Here we demonstrate that primary mouse embryonic fibroblasts (MEFs) and mammary epithelial cells (MECs) deficient in Timp3 have increased {beta}-catenin signaling. Functionally, the loss of TIMP3 exerted cell-type-specific effects, with Timp3-/- MEFs being more sensitive and Timp3-/- MECs more resistant to EGTA-induced cell detachment than the wild type. Timp3-/- MECs had higher dephosphorylated {beta}-catenin levels and increased {beta}-catenin transcriptional activity as measured by TCF/LEF-responsive reporter assays. Real-time PCR analysis of {beta}-catenin target genes in MEFs and MECs showed no alteration in Myc, decreased Ccnd1 (cyclin D1) and increased Mmp7 mRNA levels upon loss of TIMP3, with the latter occurring only in epithelial cells. Recombinant TIMP3 and synthetic metalloproteinase inhibitors reverted the increase in dephosphorylated {beta}-catenin, decrease in Ccnd1 gene expression and increase in Mmp7 gene expression. Physiologically, Timp3-/- mammary glands displayed accelerated mammary ductal elongation during pubertal morphogenesis. Gain-of-function studies using slow-release TIMP-containing pellets revealed distinct effects of individual TIMPs on ductal morphogenesis. Recombinant TIMP1, TIMP3 and TIMP4 inhibited ductal elongation whereas TIMP2 promoted this process.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
S. M. Francis, J. Bergsied, C. E. Isaac, C. H. Coschi, A. L. Martens, C. V. Hojilla, S. Chakrabarti, G. E. DiMattia, R. Khoka, J. Y. J. Wang, et al.
A Functional Connection between pRB and Transforming Growth Factor {beta} in Growth Inhibition and Mammary Gland Development
Mol. Cell. Biol., August 15, 2009; 29(16): 4455 - 4466.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Saleem, I. Murtaza, R. S. Tarapore, Y. Suh, V. M. Adhami, J. J. Johnson, I. A. Siddiqui, N. Khan, M. Asim, B. B. Hafeez, et al.
Lupeol inhibits proliferation of human prostate cancer cells by targeting {beta}-catenin signaling
Carcinogenesis, May 1, 2009; 30(5): 808 - 817.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
M. S. Anglesio, J. M. Arnold, J. George, A. V. Tinker, R. Tothill, N. Waddell, L. Simms, B. Locandro, S. Fereday, N. Traficante, et al.
Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors
Mol. Cancer Res., November 1, 2008; 6(11): 1678 - 1690.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Ali and V. Knauper
Phorbol Ester-induced Shedding of the Prostate Cancer Marker Transmembrane Protein with Epidermal Growth Factor and Two Follistatin Motifs 2 Is Mediated by the Disintegrin and Metalloproteinase-17
J. Biol. Chem., December 28, 2007; 282(52): 37378 - 37388.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2007